PRGO (Perrigo Company plc) Short-Term Debt to Capital

Corporate company logo of Perrigo Company plc (PRGO)

Risks for Perrigo Company plc (PRGO) are linked to the restructuring of its pediatric nutrition division and potential product recalls, which are weighing on profits. Meanwhile, the business relies on stable demand, leveraging massive private label production volumes to compete with brands. The price action on GURU.Markets shows that this leader in generic pharmacy products is exercising pricing power, while the separate_debt_short_eq metric stands at 0.00.

Ratio of Short-Term Indebtedness to Capital: Perrigo Company (PRGO) for 07/04/2022 - 10/30/2026
Brand item of Perrigo Company PLC

Perrigo Company plc (PRGO) investments in the automation of filling and packaging lines require liquidity management, which is reflected in the ratio of short-term liabilities to net equity. This metric measures the proportion of viable debt within the equity structure, where an increase in the short-term debt-to-equity ratio signals risks of declining profits, while its decrease limits the pace of technological development.

Competitors of Perrigo Company plc (PRGO)

Short-Term Debt to Capital HLN|KVUE (Kenvue Health) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital VRNA (Verona Pharma plc)|Short-Term Debt to Capital jyongbio.com MENS|LGND - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital AMRX (Amneal Pharmaceuticals, Inc.)|Alvotech Corp (ALVO) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Liquidia Inc.|GLPG (Galapagos NV) - Short-Term Debt to Capital|Short-Term Debt to Capital anipharmaceuticals.com|Short-Term Debt to Equity Ratio MNKD (MannKind)|AMPH (Amphastar Pharmaceuticals Inc) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Pacira PCRX|ARS Corp (SPRY) - Current Liabilities to Capital|TBPH: Short-Term Debt to Equity Ratio|aquestive.com - Short-Term Loans to Capital Ratio|SCPH: Short-Term Debt to Capital|Tectonic Therapeutic - Ratio of Short-Term Indebtedness to Capital|TNXP (Tonix Pharmaceuticals Inc.) - Short-Term Debt to Capital|Current Liabilities to Capital SXT China SXTC|Short-Term Debt to Equity Eupraxia Pharmaceuticals (EPRX)|BHST (bioharvest.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity eXoZymes EXOZ|ORMP (Oramed) - Current Liabilities to Equity|Entera Bio Corp - Short-Term Debt to Capital|Current Liabilities to Capital MindWalk Therapeutics|ABVC BioPharma (ABVC) - Short-Term Debt to Equity|cumberlandpharma.com - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Quantum BioPharma|FGEN: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital TELO|Short-Term Debt to Capital Coefficient ranitherapeutics.com|Short-Term Debt to Capital SNYR (Synergy CHC)|Short-Term Indebtedness to Equity Rallybio Corp|LEXX - Short-Term Debt to Equity|Current Liabilities to Capital Pulmatrix Inc|PTHL (ftzy.com.cn) - Short-Term Debt to Equity Ratio|Aptorum Group - Ratio of Short-Term Indebtedness to Capital|LYRA (Lyra Therapeutics, Inc.) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio impactbiomedinc.com (IBO)|Short-Term Debt to Equity TNF Pharmaceuticals (TNFA)|YCBD - Current Liabilities to Capital|Short-Term Debt to Equity PainReform Limited PRFX|CYTO - Short-Term Debt to Equity Ratio|LIPO - Short-Term Debt to Equity|Current Liabilities to Equity OPTN|PIRS: Short-Term Debt to Capital|Procaps Group (PROC) - Short-Term Debt to Capital|Short-Term Debt to Equity Petros|Short-Term Debt to Capital Ratio QLI (Qilian International Corp)|Short-Term Debt to Equity Ratio SLRN (Acelyrin, Inc.)|TFFP - Current Liabilities to Capital